- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03669978
Endovascular Procedures With Computer Assistance in the Chronic Occlusive Arthritis of the Lower Limbs on the Femoro-popliteal Stage. (PANORAMIC)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Rennes, France, 35000
- Rennes Univesity Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with peripheral arterial disease of the lower limbs, all clinical stages, lesions of the femoro-popliteal stage and candidates for endovascular treatment of these lesions.
- Major patients
- Patients not opposed to their participation in the study
Exclusion Criteria:
- Patients requiring conventional surgical revascularization.
- Patient under legal protection (guardianship, safeguard of justice).
- Pregnant or lactating women
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients with chronic occlusive arthritis of the Lower Limbs
Patients with chronic occlusive arthritis of the Lower Limbs with lesions on the femoro-popliteal stage and candidates for endovascular treatment of these lesions. Creation of a bone and arterial panorama using EndoNaut® software. |
The routine care procedure begins with staged injections of contrast medium to provide a map of the lesions. The lesions are then treated by angioplasty with or without stenting. New injections of contrast product are made to control the results of the treatment. As part of this pilot study, the assistive software and its interface will be linked and with the mobile C-arm X-ray system. Scopic images and angiograms will be retransmitted to be processed by the EndoNaut® software.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantification of the registration errors
Time Frame: At the inclusion day
|
The 2D-2D registration is driven by an error index (intrinsic software criterion) given by the software at the end of the registration process
|
At the inclusion day
|
|
Volume of contrast product used during the routine care procedure (ml)
Time Frame: At the inclusion day
|
Volume are reported in mL
|
At the inclusion day
|
|
Irradiation parameters: evaluation of the Fluoroscopy duration (min)
Time Frame: At the inclusion day
|
Parameter given by the X-ray imaging device
|
At the inclusion day
|
|
Irradiation parameters: dose-area quantification (mGy/m2)
Time Frame: At inclusion
|
Parameter given by the X-ray imaging device
|
At inclusion
|
|
Irradiation parameters: measurement of air Kerma (mGy)
Time Frame: At the inclusion day
|
Parameter given by the X-ray imaging device
|
At the inclusion day
|
|
Irradiation parameters: evaluation of the number of required angiograms
Time Frame: At the inclusion day
|
Parameter given by the X-ray imaging device
|
At the inclusion day
|
|
Operating time (min)
Time Frame: At the inclusion day
|
Delay between the beginning (patient anesthesia) and the end (patient transferred to post interventional care room) of the procedure
|
At the inclusion day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Adrien Kaladji, MD, Rennes University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35RC17_3070
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
Marissa JarosinskiTerminatedPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
OrbusNeichEucatech AG; Centre Européen de Recherche CardiovasculaireRecruitingPeripheral Arterial Disease | Peripheral Arterial Occlusive DiseaseSpain, Singapore, Belgium, Germany
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Wroclaw Medical UniversityPoznan University of Medical Sciences; Military Institute of Medicine National...RecruitingPeripheral Arterial Disease(PAD)Poland
-
BayerCompleted
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Peripheral Artery Occlusive DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
Clinical Trials on Creation of a bone and arterial panorama using EndoNaut® software.
-
Cairo UniversityRecruiting
-
Northern Orthopaedic Division, DenmarkVejle Hospital; Randers Regional Hospital; Central Jutland Regional Hospital; Swemac...CompletedDisplaced Midshaft Fracture of the Collar BoneDenmark
-
Hospices Civils de LyonRecruiting
-
University Hospital, Clermont-FerrandFondation ApicilCompletedNeuropathic Traumatic Pain | Pain NRS ≥ 4 | Peripheral Neuropathic Pain | Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4France
-
University Hospital, MontpellierNational Cancer Institute, FranceUnknownMetastatic Head-and-neck Squamous-cell CarcinomaFrance
-
University of Santiago de CompostelaGeistlich Pharma AG; StraumanngroupCompletedPatients with Posterior Maxillary Atrophy and Need for Sinus Lift Surgery to Allow Implant PlacementSpain
-
South Valley UniversityIbn Sina Hospital; Qena Fertility Center, Qena, EgyptUnknownImprovement of Embryo Transfer Technique | Improvement of Implantation
-
Centre Hospitalier de MontaubanRecruiting
-
Centre hospitalier de l'Université de Montréal...Terminated
-
Red Rock Regeneration Inc.Enrolling by invitationSurgery | Foot Deformities | Ankle ArthropathyCanada